| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Yeganeh Reuven | Director, 10%+ Owner | C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4, NESS ZIONA | /s/ Reuven Yeganeh | 16 Jan 2026 | 0002044677 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | PHGE | Series Y Convertible Preferred Stock | 13 Jan 2026 | Common Stock | 1,650,000 | $2.00 | By Pyu Pyu Capital, LLC | F1, F2 | ||||||
| holding | PHGE | Common Stock Purchase Warrants | 13 Jan 2026 | Common Stock | 3,300,000 | $2.00 | By Pyu Pyu Capital, LLC | F2 |
| Id | Content |
|---|---|
| F1 | Each share of Series Y Convertible Preferred Stock is initially convertible into common stock at a conversion price of $2.00 per share, subject to customary anti-dilution adjustments for stock splits, stock dividends, recapitalizations and similar transactions. In addition, upon receipt of the requisite stockholder approval, the conversion price may be adjusted as provided in the Certificate of Designation. |
| F2 | The reported securities are held by Pyu Pyu Capital, LLC, of which the reporting person is the sole member, and over which the reporting person exercises sole voting and dispositive power. |